Authors:
GION M
BARIOLI P
PONTI A
TORRI V
MIONE R
DITTADI R
Citation: M. Gion et al., HOW CA-125 IS USED IN THE ROUTINE FOLLOW-UP OF OVARIAN-CANCER - A SURVEY OF 29 ITALIAN HOSPITALS, Tumor biology, 19(4), 1998, pp. 269-274
Authors:
MIONE R
AIMO G
BOMBARDIERI E
CIANETTI A
CORREALE M
BARIOLI P
BARICHELLO M
TERRONE C
MASSARON S
SEREGNI E
MARZANO D
ABBATE I
PAGLIARULO A
GION M
Citation: R. Mione et al., PRELIMINARY-RESULTS OF CLINICAL-EVALUATION OF THE FREE TOTAL PROSTATE-SPECIFIC ANTIGEN RATIO IN A MULTICENTRIC STUDY/, Tumori, 82(6), 1996, pp. 543-549
Authors:
DITTADI R
BARIOLI P
GION M
MIONE R
BARICHELLO M
CAPITANIO G
COCCO G
CAZZOLATO G
DEBLASI F
PRATURLON S
ANTINOZZI R
GIANNEO E
Citation: R. Dittadi et al., STANDARDIZATION OF ASSAY FOR CYTOKERATIN RELATED TUMOR-MARKER CYFRA21.1 IN URINE SAMPLES, Clinical chemistry, 42(10), 1996, pp. 1634-1638
Authors:
GION M
BARIOLI P
MIONE R
CAPPELLI G
VIGNATI G
FORTUNATO A
SARACCHINI S
BIASIOLI R
GUSLISANO M
Citation: M. Gion et al., TUMOR-MARKERS IN BREAST-CANCER FOLLOW-UP - A POTENTIALLY USEFUL PARAMETER STILL AWAITING DEFINITIVE ASSESSMENT, Annals of oncology, 6, 1995, pp. 31-35
Authors:
BARICHELLO M
GION M
BONAZZA A
PONTI USD
BOLGAN A
CONTEMORI GP
BARIOLI P
CAPITANIO G
PECORI B
OMACINI S
BENVEGNU L
PETRACCO S
Citation: M. Barichello et al., PROSTATE-SPECIFIC ANTIGEN AS A UNIQUE ROUTINE TEST IN MONITORING THERAPY FOR INOPERABLE PROSTATE-CANCER - COMPARISON WITH RADIONUCLIDE BONE-SCAN AND PROSTATIC ACID-PHOSPHATASE, European urology, 27(4), 1995, pp. 295-300
Authors:
GION M
MIONE R
BARIOLI P
SARTORELLO P
CAPITANIO G
Citation: M. Gion et al., TISSUE POLYPEPTIDE ANTIGEN AND TISSUE POLYPEPTIDE SPECIFIC ANTIGEN INPRIMARY BREAST-CANCER - EVALUATION IN SERUM AND TUMOR-TISSUE, European journal of clinical chemistry and clinical biochemistry, 32(10), 1994, pp. 779-787